Tony M. Chou

Tony M. Chou, MD has over 15 years of healthcare experience as both an interventional cardiologist and medical device industry executive. Dr. Chou was employed by the Abbott Vascular Division of Abbott Laboratories at which he held positions with both general management and business development responsibilities. Serving as Vice President and General Manager of Vascular Closure, he oversaw the development, manufacturing, clinical trials, FDA PMAS/PMA and global launches of the femoral closure devices Perclose Proglide and StarClose. Prior to joining Abbott, Dr. Chou was the Director of the Adult Cardiac Catheterization Laboratory at the University of California, San Francisco where he remains Associate Professor of Medicine. He serves on the advisory board for UCSF’s Masters of Translational Medicine program as well as Case Western Reserve’s Council for the Advancement of Human Health. In addition, Dr. Chou currently serves as director or advisor to boards of Silk Road Medical, Outset Medical, Singular Bio, Omada Health, and Hinge. He also serves as founder, CEO and Director of Route 92 Medical. He previously served on the Board of Directors of Lutonix. Dr. Chou received an MD from Case Western Reserve University and a BS in Physics and Electrical Engineering from Carnegie Mellon University.